Clinical trial

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and…

NCT00198068 · Hospital for Special Surgery, New York, Other · Recruiting

Key facts

NCT number NCT00198068
Title Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Official title Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Acronym PROMISSE
Lead sponsor Hospital for Special Surgery, New York, Other
Collaborators National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH
Status Recruiting
Study type Observational
Conditions Systemic Lupus Erythematosus, Antiphospholipid Syndrome
Enrollment 700
Start date Sep 1, 2003
Primary completion Mar 1, 2026
Completion Mar 1, 2026
First posted Sep 20, 2005
Last update posted Apr 13, 2025
Countries Canada, United Kingdom, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies